Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis [PDF]
Korean Journal of Anesthesiology, 2011 BackgroundPostoperative nausea and vomiting (PONV) remains a challenge for patients and health professionals despite various newly developed prophylactic interventions.
Won Oak Kim +3 more
doaj +1 more source
, 2018 BACKGROUND: Delayed nausea after chemotherapy remains a symptom of interest. Clinicians often provide additional and/or pro re nata (p.r.n.) antiemetics with guideline-consistent antiemetics in an attempt to achieve further symptom control.
김혜련 +3 more
core +1 more source
Helping patients discuss CINV management : development of a patient charter [PDF]
, 2013 In April 2012, an Expert Group of specialist cancer nurses working in a variety of settings (e.g. chemotherapy delivery, chemotherapy service design, research, nurse leadership and patient information/advocacy) participated in telephone/web-based ...
Dielenseger, Pascale +10 more
core +1 more source
Need for rescue antiemetics grouped by concomitant antiemetics.
, 2014 Six studies described the need for rescue antiemetics in thyroidectomy patients treated with dexamethasone versus placebo with or without concomitant antiemetics (RR 0.42, 95% CI 0.30 to 0.57 ...
Zhenhong Zou (645858) +3 more
core +1 more source
Pharmaceutical policy and off-label prescribing in pregnancy: A population-based historical cohort study analyzing inequality in access to antiemetics within Australia's Pharmaceutical Benefits Scheme. [PDF]
Acta Obstet Gynecol ScandPublic spending on antiemetics among pregnant women in Australia is concentrated in socioeconomically disadvantaged women. However, public expenditure is also driven by off‐label ondansetron use (i.e., use outside regulatory‐approved indications), highlighting a misalignment between pharmaceutical policy, public expenditure patterns, and pregnant women'
Jackson H +4 more
europepmc +2 more sources
A Scoping Review of 5-HT<sub>3</sub> Antagonist Antiemetic Medication Safety in the Management of Nausea and Vomiting of Pregnancy. [PDF]
Pharmacoepidemiol Drug SafABSTRACT Purpose The prescribing of 5‐hydroxytryptamine 3 receptor and type 3 serotonin receptor (5‐HT3) antagonists, particularly ondansetron, for nausea and vomiting in pregnancy (NVP) has increased globally. However, evidence on the safety of these medications in pregnancy remains unclear.
Morgan S +6 more
europepmc +2 more sources
Efficacy of antiemetics in patients receiving XELOX – a single-centre, prospective study [PDF]
, 2011 Background: XELOX (combination therapy of capecitabine and oxaliplatin) is known to cause nausea and vomiting, despite adequate administration of antiemetics.
A. Chan +10 more
core +1 more source
Paradoxical effects of prophylactic phenothiazine antiemetics in children receiving chemotherapy.
, 1984 The effectiveness of prophylactic phenothiazine antiemetics on reduction of nausea and vomiting was assessed for 23 children (age, 9-17 years) who had intermittently received antiemetics (ie, for one course but not for another). Each patient was his own
P M Zeltzer, S LeBaron, L Zeltzer
core +1 more source
Postdischarge nausea and vomiting (PDNV) in children: A review and observational study
Biomedical Papers, 2023 Postdischarge nausea and vomiting (PDNV) cause substantial pediatric morbidity with potentially serious postoperative complications. However, few studies have addressed PDNV prevention and treatment in pediatric patients.
Michal Frelich +6 more
doaj +1 more source
American Journal of Hematology, EarlyView.ABSTRACT Asparaginase is a critical treatment component for patients with acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). However, the successful delivery of asparaginase‐based therapy remains challenging across care settings due to its complex administration, distinct toxicity profile, prolonged treatment duration, and the need for ...
Amir Ali +8 more
wiley +1 more source